Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
Significant corporate and scientific progress in the first half of 2024 Advancement of lead program MDG1015 with IND filing on track for 3Q 2024 and CTA filing for 4Q 2024 New additions to End-to-End Platform technologies and IP portfolio Partnership …